The other day, a headline in my inbox threw me for a loop: “McKinsey to pay $573 million for role in opioid crisis.” It wasn’t the headline itself that surprised me. The idea that the most prestigious management consulting firm in the world helped its client “turbocharge” sales of an addictive painkiller that claimed over 450,000… Continue reading McKinsey & the Opioid Crisis
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.